Clinical Trial Update: Eicosapentaenoic Acid and Protein Modulation to Induce Anabolism in Chronic Obstructive Pulmonary Disease (COPD): Aim 2 [NA]

View source ↗

Summary

A completed clinical trial evaluated whether eicosapentaenoic acid (EPA) and protein modulation can induce anabolic effects in people with chronic obstructive p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease
• Muscle Wasting

Drugs mentioned

• Eicosapentaenoic acid (eicosapentaenoic acid)

Snippet

Sponsor: Texas A&M University | Conditions: Chronic Obstructive Pulmonary Disease, Muscle Wasting | NA | Status: COMPLETED